Kymera Therapeutics, Inc.

NASDAQ:KYMR

29.49 (USD) • At close May 23, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22019 Q4
Assets:
Current Assets:
Cash & Cash Equivalents 89.966120.256110.71867.61293.51109.96681.05152.38650.15268.395155.65876.91433.73347.976156.81984.90353.09831.00454.59360.97176.015
Short Term Investments 373.184368.488439.252442.341427.034264.915276.774315.188346.725338.771326.25315.395387.079394.442379.567274.204280.439265.198239.24894.99415.942
Cash and Short Term Investments 463.15488.744549.97509.953520.544374.881357.825367.574515.894559.494481.908392.309420.812567.605536.386359.107333.537458.733293.841155.96591.957
Net Receivables 00.9471.3171.7042.0318.7623.7784.1223.322.5372.8822.371.2630.1351.5730.9041.7341.4330.57700
Inventory 00000000-14.673-12.25000-8.855000-162.531000
Other Current Assets 37.80120.57717.42813.7514.67911.67414.09113.70611.3539.71318.46416.1829.30717.4411.5444.7955.529.4082.9462.3360.888
Total Current Assets 500.951510.268568.715525.407537.253405.317375.694385.402515.894559.494494.022402.77431.382567.605543.731364.806340.791302.339297.364158.30192.845
Non-Current Assets:
Property, Plant & Equipment, Net 95.90697.86499.309100.43998.665101.07991.183.18174.03613.33421.61721.92921.06611.88121.72421.76620.50210.84120.94320.28522.083
Goodwill 000000000000000000000
Intangible Assets 000000000000000000000
Goodwill and Intangible Assets 000000000000000000000
Long Term Investments 0362.159361.035198.286230.21561.43476.988104.759119.017152.328113.70190.182102.478125.18774.69245.305101.639162.531187.46400
Tax Assets 000000000000000000000
Other Non-Current Assets 321.4557.7445.7831.8892.1187.9298.5968.603-95.042-122.0229.1328.548.134-98.7682.3062.5091.6211.4641.592.5231.774
Total Non-Current Assets 417.361467.767466.127300.614330.998170.442176.684196.54398.01143.64144.45120.651131.67838.398.72269.58123.761184.836209.99722.80823.857
Total Assets 918.312978.0351,034.842826.021868.251575.759552.378581.945613.905603.134638.472523.421563.06605.905642.453434.386464.552487.175507.361181.109116.702
Liabilities & Equity:
Current Liabilities:
Account Payables 10.2635.9896.4946.516.8127.0754.9783.7456.4834.3356.3272.3742.5674.0055.0338.1778.3484.3683.9793.9823.276
Short Term Debt 13.2413.11225.70224.8329.8912.697.197.5943.8933.9437.2387.3127.1343.5997.2646.9266.0963.2612.7333.7053.377
Tax Payables 000000000000000000000
Deferred Revenue 11.47613.57620.02419.25922.61337.88327.35224.30257.11463.2655.77659.4660.852101.03466.23482.26387.912170.3992.01127.28923.349
Other Current Liabilities 13.74735.0914.31211.54216.82128.04323.64618.96119.30927.80521.78318.35417.78623.19915.96211.3197.78110.4368.5637.7044.568
Total Current Liabilities 58.98967.76766.53262.14356.13685.69163.16654.602123.54363.2691.12487.588.339101.03494.493108.685110.137110.617107.28642.6834.57
Non-Current Liabilities:
Long Term Debt 73.0974.64975.38151.5377.131156.658154.496142.528129.72813.39226.24227.2727.8114.36429.6229.68228.84414.73230.16415.39917.816
Deferred Revenue Non-Current 0003.18923.78116.76816.42120.42124.8662821.08624.07131.82339.29549.93952.67264.65477.83890.30818.98729.642
Deferred Tax Liabilities Non-Current 000-3.189-23.781-16.7680000000-53.6590000-15.0820-17.816
Other Non-Current Liabilities 000-75.7650-78.329-77.24-71.034-64.6270.248-12.865-13.371-13.6320.066-14.734-14.757-14.330.1-15.0820109.08
Total Non-Current Liabilities 73.0974.64975.3878.954100.91295.09793.67791.91528.35749.72334.46337.9746.00145.23364.82567.59779.16892.67105.3934.386156.538
Total Liabilities 132.079142.416141.912141.097157.048180.788156.843146.517151.9112.983125.587125.47134.34146.267159.318176.282189.305203.287212.67677.066191.108
Equity:
Preferred Stock 000000000000000000507.36100
Common Stock 0.0070.0070.0070.0060.0060.0060.0060.0060.0060.0060.0060.0050.0050.0050.0050.0050.0040.0040.0040.0030
Retained Earnings -820.191-754.61-683.858-621.371-579.309-530.752-516.384-463.517-424.718-383.79-348.925-305.923-265.666-228.982-195.082-166.5-141.84-128.765-116.08-108.094-76.456
Accumulated Other Comprehensive Income/Loss -0.058-1.4851.931-2.099-1.777-0.552-2.45-3.635-3.038-4.949-5.913-3.983-3.216-0.66-0.1460-0.013-0.128-0.1640.0310.006
Other Total Stockholders Equity 1,606.4751,591.7071,574.851,308.3881,292.283926.269914.363902.574889.755878.884867.717707.852697.597689.275678.358424.599417.096412.777410.925212.1062.044
Total Shareholders Equity 786.233835.619892.93684.924711.203394.971395.535435.428462.005490.151512.885397.951428.72459.638483.135258.104275.247283.888294.685104.043-74.406
Total Equity 0835.619892.93684.924711.203394.971395.535435.428462.005490.151512.885397.951428.7200000000
Total Liabilities & Shareholders Equity 918.312978.0351,034.842826.021868.251575.759552.378581.945613.905603.134638.472523.421563.06605.905642.453434.386464.552487.175507.361181.109116.702